1 |
Song et al. |
Biochem. Biophys. Res. Commun. |
2009 |
19665999 |
MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1. |
2 |
Hurteau et al. |
Cell Cycle |
2009 |
19502803 |
Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. |
3 |
Gregory et al. |
Nat. Cell Biol. |
2008 |
18376396 |
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. |
4 |
Lee et al. |
Oncogene |
2014 |
23474752 |
Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. |
5 |
Gandellini et al. |
Cell Death Differ. |
2012 |
22555458 |
miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. |
6 |
Riley et al. |
EMBO J. |
2012 |
22473208 |
EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. |
7 |
Hulf et al. |
Oncogene |
2013 |
22869146 |
Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer. |
8 |
Mouillet et al. |
FASEB J. |
2010 |
20065103 |
MiR-205 silences MED1 in hypoxic primary human trophoblasts. |
9 |
Dar et al. |
J. Biol. Chem. |
2011 |
21454583 |
miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. |
10 |
Piovan et al. |
Mol Oncol |
2012 |
22578566 |
Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. |
11 |
Noguchi et al. |
Mol. Ther. |
2013 |
23629002 |
Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo. |
12 |
Iorio et al. |
Cancer Res. |
2009 |
19276373 |
microRNA-205 regulates HER3 in human breast cancer. |
13 |
Wang et al. |
Cell Death Dis |
2013 |
23519125 |
Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells. |
14 |
Barker et al. |
Curr Opin Pharmacol |
2010 |
20864407 |
Regulation of ErbB receptor signalling in cancer cells by microRNA. |
15 |
Wu et al. |
Cell Res. |
2009 |
19238171 |
Suppression of cell growth and invasion by miR-205 in breast cancer. |
16 |
Gandellini et al. |
Cancer Res. |
2009 |
19244118 |
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. |
17 |
Majid et al. |
Cancer |
2010 |
20737563 |
MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. |
18 |
Kim et al. |
Mol. Cells |
2013 |
23212344 |
MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells. |
19 |
Muratsu-Ikeda et al. |
PLoS ONE |
2012 |
22859986 |
Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells. |
20 |
Alla et al. |
Cell Cycle |
2012 |
22871739 |
E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry. |
21 |
Xie et al. |
PLoS ONE |
2012 |
23056551 |
miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. |
22 |
Adachi et al. |
Biochem. Biophys. Res. Commun. |
2011 |
21787752 |
ErbB2 down-regulates microRNA-205 in breast cancer. |
23 |
Cho et al. |
Hum. Mol. Genet. |
2013 |
23125283 |
MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. |
24 |
Majid et al. |
Cancer Res. |
2011 |
21330408 |
MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. |
25 |
Lipchina et al. |
Genes Dev. |
2011 |
22012620 |
Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. |
26 |
Tian et al. |
Med. Oncol. |
2014 |
24297308 |
MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma. |
27 |
Verdoodt et al. |
Int. J. Oncol. |
2013 |
23612742 |
MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. |
28 |
Tabruyn et al. |
Angiogenesis |
2013 |
23800974 |
MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells. |
29 |
Yin et al. |
Eur Rev Med Pharmacol Sci |
2014 |
24763883 |
Down-regulation of microRNA-205 promotes gastric cancer cell proliferation. |
30 |
Luo et al. |
J Transl Med |
2013 |
23497265 |
A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells. |
31 |
Hagman et al. |
Br. J. Cancer |
2013 |
23571738 |
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. |
32 |
Karginov et al. |
Genes Dev. |
2013 |
23824327 |
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. |
33 |
Motsch et al. |
PLoS ONE |
2012 |
22870299 |
MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing. |
34 |
Cui et al. |
Biochem. Biophys. Res. Commun. |
2014 |
24576478 |
Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4. |
35 |
Larzabal et al. |
Br. J. Cancer |
2014 |
24434435 |
TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis. |
36 |
Cui et al. |
Biochem. Biophys. Res. Commun. |
2014 |
24462768 |
MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. |
37 |
Xue et al. |
Cell |
2013 |
23313552 |
Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. |
38 |
Memczak et al. |
Nature |
2013 |
23446348 |
Circular RNAs are a large class of animal RNAs with regulatory potency. |
39 |
Whisnant et al. |
MBio |
2013 |
23592263 |
In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. |
40 |
Kishore et al. |
Nat. Methods |
2011 |
21572407 |
A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. |
41 |
Elgamal et al. |
PLoS ONE |
2013 |
24098490 |
Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. |
42 |
Cai et al. |
Cancer Res. |
2013 |
23856247 |
miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. |
43 |
Lei et al. |
Oncol. Rep. |
2013 |
24084898 |
miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN. |
44 |
Wang et al. |
Oncol. Rep. |
2013 |
23564023 |
SZ-685C exhibits potent anticancer activity in both radiosensitive and radioresistant NPC cells through the miR-205-PTEN-Akt pathway. |
45 |
Su et al. |
Oncol. Rep. |
2013 |
23589079 |
miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma. |
46 |
Lin et al. |
Invest. Ophthalmol. Vis. Sci. |
2013 |
23950153 |
Inhibition of miR-205 impairs the wound-healing process in human corneal epithelial cells by targeting KIR4.1 (KCNJ10). |
47 |
Gottwein et al. |
Cell Host Microbe |
2011 |
22100165 |
Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. |
48 |
Farazi et al. |
Genome Biol. |
2014 |
24398324 |
Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. |
49 |
Hafner et al. |
Cell |
2010 |
20371350 |
Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. |
50 |
Chi et al. |
Nature |
2009 |
19536157 |
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. |
51 |
Majoros et al. |
Nat. Methods |
2013 |
23708386 |
MicroRNA target site identification by integrating sequence and binding information. |
52 |
Skalsky et al. |
PLoS Pathog. |
2012 |
22291592 |
The viral and cellular microRNA targetome in lymphoblastoid cell lines. |